Professor, Medicine, Georgetown University School of Medicine
Oncology
Dr. Claudine J. Isaacs, MD
|
|
Give Review
Dr. Claudine J. Isaacs works in the field of Oncology. She has 8 awards "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "America's Top Doctors for Cancer", "Top Doctors:Washington-Baltimore", "Top Doctors:Washington DC Area", "Women's Health", "Northern Virginia Magazine" and "Whos Who in Medicine and Healthcare". Dr. Claudine J. Isaacs is a published doctor and has 22 publications published. The lastest was: 'Hormone replacement therapy in women with a history of breast carcinoma.' Claudine Isaacs accepts all Medicare patients.
Publications
- Population-based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast Cancer patients under the age of 65 years.
- Adoption of Gene Expression Profiling for Breast Cancer in US Oncology Practice for Women Younger Than 65 Years.
- Patterns of 21-gene assay testing and chemotherapy use in black and white breast Cancer patients.
- The Neoadjuvant Model is Still the Future for Drug Development in Breast Cancer.
- Treatment of primary breast tumors in de novo metastatic breast Cancer.
- SWOG S0221: A Phase III Trial Comparing Chemotherapy Schedules in High-Risk Early-Stage Breast Cancer.
- Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers.
- Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.
- Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data.
- Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast Cancer survivors: CALGB/Alliance 369901.
- Cognitive impairment in older patients with breast Cancer before systemic therapy: is there an interaction between Cancer and comorbidity?
- Frailty and Adherence to Adjuvant Hormonal Therapy in Older Women With Breast Cancer: CALGB Protocol 369901.
- Risk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast Cancer: a population-based study.
- A planned, prospective comparison of short-term quality of life outcomes among older patients with breast Cancer treated with standard chemotherapy in a randomized cli...
- Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast Cancer.
- A Peer-Led Decision Support Intervention Improves Decision Outcomes in Black Women with Breast Cancer.
- Narrowing racial gaps in breast Cancer chemotherapy initiation: the role of the patient-provider relationship.
- Conveying genomic recurrence risk estimates to patients with early-stage breast Cancer: oncologist perspectives.
- Association of Rad51 polymorphism with DNA repair in BRCA1 Mutation Carriers and Sporadic Breast Cancer Risk.
- Long-term satisfaction and quality of life following risk reducing surgery in BRCA1/2 mutation carriers.
- Hormone replacement therapy in women with a history of Breast carcinoma.
Schools
McGill University Faculty of Medicine
Montreal General Hospital
Georgetown University
McGill University
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors for Cancer
- Top Doctors:Washington-Baltimore
- Top Doctors:Washington DC Area
- Women's Health
- Northern Virginia Magazine
- Whos Who in Medicine and Healthcare
Education
-
McGill University Faculty of Medicine
Hospital
-
MedStar Georgetown University Hospital
Drug Facts
| NPI NUMBER | 1164414751 | |
| NPPES Provider LastName | ISAACS | |
| NPPES Provider FirstName | CLAUDINE | |
| NPPES Provider ZIPCode | 200072113 | |
| NPPES Provider State | DC | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 131.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1164414751 |
| Last Name Of The Provider | ISAACS |
| First Name Of The Provider | CLAUDINE |
| View All |
Similar Doctors
|
|
Dr. Paula R. Pohlmann, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul G. Kluetz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan L. Honig, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ekatherine Asatiani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adrianne P. Kelly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julia A. Beaver, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deepa S. Subramaniam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sandra J. Ginsberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey K. Klotz, MD
This Doctor is OpenDoctor Recommended.
|